Gait Pattern and Its Relation to Cognition and VEP in Multiple Sclerosis

NCT07847086 — Not yet recruiting, 70 participants, Assiut University
ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Pattern of Gait and Assessment Regarding Pathophysiology and Mechanism and Its Relation to Cognition, VEP, and Radiology as Prediction of Progression of Disease in Multiple Sclerosis Patients

RegistryNCT07847086
StatusNot yet recruiting
Study typeObservational
Enrollment70 (Estimated)
SponsorAssiut University (Other)
ConditionsMultiple Sclerosis, Gait Disorders, Neurologic
Datesstart 2026-09-26 (estimated), primary completion 2027-09-26 (estimated), completion 2028-03-01 (estimated), first posted 2026-09-29, last updated 2026-10-01

Related Papers Related Patents Related Grants Related Experts
All trials for Multiple Sclerosis All trials for Gait Disorders, Neurologic

-Summary

This cross-sectional study aims to assess the pattern of gait in patients with multiple sclerosis and to evaluate its relation to cognitive function, visual evoked potentials, and radiological findings.

Expand all sections  ·  Collapse all

+Detailed description

Gait impairment is a common and disabling feature of multiple sclerosis. This observational study will include patients with confirmed multiple sclerosis according to the revised McDonald criteria who are clinically stable.

Participants will undergo quantitative gait analysis, cognitive assessment, visual evoked potential testing, and review of MRI findings in a single assessment visit.

+Arms and interventions

ArmTypeInterventionsDescription
Single cohort: Multiple Sclerosis PatientsPatients with confirmed multiple sclerosis who will undergo gait analysis, cognitive testing, visual evoked potential assessment, and MRI review in a single visit.

+Outcome measures

Primary outcomes

  • Mean gait velocity [Baseline]: Mean gait velocity in meters per second measured by quantitative spatiotemporal gait analysis.

Secondary outcomes

  • Mean cadence [Baseline]: Mean cadence in steps per minute measured by quantitative gait analysis.
  • Mean stride length [Baseline]: Mean stride length in centimeters measured by quantitative gait analysis.
  • Mean MoCA score [Baseline]: Mean Montreal Cognitive Assessment (MoCA) score (range 0-30, higher scores indicate better cognition).
  • Mean P100 latency [Baseline]: Mean P100 latency in milliseconds measured by pattern-reversal visual evoked potentials.
  • Mean EDSS score [Baseline]: Mean Expanded Disability Status Scale (EDSS) score (range 0-10, higher scores indicate worse disability).

+Eligibility

Sex: All, ages: 18 Years to 55 Years

Inclusion Criteria:

* \- Age 18 to 55 years
* Confirmed diagnosis of multiple sclerosis according to the revised McDonald criteria
* Clinically stable (no relapse or steroid treatment within 4 weeks)
* Able to walk independently with or without a single assistive device
* Written informed consent

Exclusion Criteria:

* \- Other neurological, orthopedic, visual, or vestibular conditions affecting gait
* Severe cognitive impairment precluding valid testing
* Pregnancy
* MRI contraindications
* Ocular disease unrelated to multiple sclerosis

+Investigators